系统性疾病与OSA手术治疗及CPAP的比较
这项回顾性队列研究利用Truven MarketScan数据库(2007-2015年)纳入54 224例40-89岁OSA患者,比较单纯CPAP处方与软组织或骨性手术治疗后心血管、神经和内分泌并发症的发生情况。倾向评分匹配校正后,软组织手术与较低的心血管、神经和内分泌事件风险相关,而骨性手术未见显著差异。
要点
- 软组织手术与较低的心血管、神经和内分泌并发症风险相关。
- 骨性手术及联合手术未见系统性并发症风险的显著差异。
- 研究提示对CPAP失败或依从性高风险患者可考虑早期手术。
核心结论
- 在大型工作保险成人样本中,OSA软组织手术相比CPAP处方与较低的心血管、神经和内分泌系统性并发症发生率相关。
主要发现
- 未校正模型中,软组织手术与心血管事件(HR 0.92;95%CI 0.86-0.98)、神经事件(HR 0.49;95%CI 0.39-0.61)和内分泌事件(HR 0.80;95%CI 0.74-0.86)减少相关。
- 校正模型中,软组织手术与心血管事件(HR 0.91;95%CI 0.83-1.00)、神经事件(HR 0.67;95%CI 0.51-0.89)和内分泌事件(HR 0.82;95%CI 0.74-0.91)减少相关。
- 骨性手术(n=114)及骨性与软组织联合手术(n=18)未显示系统性并发症发生率的显著差异。
临床怎么用
- 对于CPAP失败或依从性高风险的患者,可考虑将软组织手术纳入早期治疗算法。
局限性
- 本研究为回顾性队列研究,使用便利样本,可能存在未测量的混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: The efficacy of surgical treatments for obstructive sleep apnea (OSA) is variable when considering only the Apnea Hypopnea Index as the treatment end point. However, only a few studies have shown an association between these procedures and improved clinically relevant outcomes, such as cardiovascular, endocrine, and neurological sequelae of OSA. OBJECTIVE: To evaluate the association of surgery for OSA with clinically relevant outcomes. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study used the Truven MarketScan Database from January 1, 2007, to December 31, 2015, to identify all patients diagnosed with OSA who received a prescription of continuous positive airway pressure (CPAP), were 40 to 89 years of age, and had at least 3 years of data on file. Data were analyzed September 19, 2019. INTERVENTIONS: Soft tissue and skeletal surgical procedures for the treatment of OSA. MAIN OUTCOMES AND MEASURES: The occurrence of cardiovascular, neurological, and endocrine complications was compared in patients who received CPAP alone and those who received surgery. High-dimensionality propensity score matching was used to adjust the models for confounders. Kaplan-Meier survival analysis with a log-rank test was used to compare differences in survival curves. FINDINGS: A total of 54 224 patients were identified (33 405 men [61.6%]; mean [SD] age, 55.1 [9.2] years), including a cohort of 49 823 patients who received CPAP prescription alone (mean [SD] age, 55.5 [9.4] years) and 4269 patients who underwent soft tissue surgery (mean [SD] age, 50.3 [7.0] years). The median follow-up time was 4.47 (interquartile range, 3-8) years after the index CPAP prescription. In the unadjusted model, soft tissue surgery was associated with decreased cardiovascular (hazard ratio [HR], 0.92; 95% CI, 0.86-0.98), neurological (HR, 0.49; 95% CI, 0.39-0.61), and endocrine (HR, 0.80; 95% CI, 0.74-0.86) events. This finding was maintained in the adjusted model (HR for cardiovascular events, 0.91 [95% CI, 0.83-1.00]; HR for neurological events, 0.67 [95% CI, 0.51-0.89]; HR for endocrine events, 0.82 [95% CI, 0.74-0.91]). Skeletal surgery (n = 114) and concomitant skeletal and soft tissue surgery (n = 18) did not demonstrate significant differences in rates of development of systemic complications. CONCLUSIONS AND RELEVANCE: In this cohort study, soft tissue surgery for OSA was associated with lower rates of development of cardiovascular, neurological, and endocrine systemic complications compared with CPAP prescription in a large convenience sample of the working insured US adult population. These findings suggest that surgery should be part of the early treatment algorithm in patients at high risk of CPAP failure or nonadherence.
引用
- Ibrahim B, de Freitas Mendonca MI, Gombar S, et al. Association of Systemic Diseases With Surgical Treatment for Obstructive Sleep Apnea Compared With Continuous Positive Airway Pressure. JAMA Otolaryngol Head Neck Surg. 2021. PMID: 33475682. doi:10.1001/jamaoto.2020.5179
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。